Stock 600774 HANSHANG GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hanshang Group Co., Ltd.

Equities

600774

CNE000000NC5

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
7.25 CNY +0.55% Intraday chart for Hanshang Group Co., Ltd. +6.46% -26.47%
Apr. 25 Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,216 2,533 3,109 4,915 3,294 2,850
Enterprise Value (EV) 1 3,508 2,913 4,017 5,424 4,074 3,611
P/E ratio 164 x 84.8 x 68.4 x 52.6 x 37.6 x 47.5 x
Yield 0.21% - - 0.6% 0.53% -
Capitalization / Revenue 2.97 x 2.19 x 6.28 x 3.36 x 2.38 x 2.05 x
EV / Revenue 3.24 x 2.52 x 8.11 x 3.7 x 2.94 x 2.6 x
EV / EBITDA 29.3 x 24.1 x 69.4 x 21.8 x 19.7 x 14.6 x
EV / FCF -428 x -27.9 x 50.9 x -15.5 x -56.9 x 15.5 x
FCF Yield -0.23% -3.58% 1.97% -6.46% -1.76% 6.46%
Price to Book 5.38 x 4.08 x 4.69 x 2.98 x 1.98 x 1.74 x
Nbr of stocks (in thousands) 226,948 226,948 226,948 295,032 291,781 289,008
Reference price 2 14.17 11.16 13.70 16.66 11.29 9.860
Announcement Date 4/27/19 4/29/20 3/30/21 3/30/22 4/25/23 4/25/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,082 1,157 495.2 1,465 1,387 1,390
EBITDA 1 119.7 120.7 57.9 248.7 206.3 246.7
EBIT 1 55.61 52.48 -17.27 138.7 83.22 116
Operating Margin 5.14% 4.53% -3.49% 9.47% 6% 8.35%
Earnings before Tax (EBT) 1 34.23 47.43 47.12 107.8 94.28 73.79
Net income 1 19.57 29.87 45.49 85.68 88.48 61.21
Net margin 1.81% 2.58% 9.19% 5.85% 6.38% 4.4%
EPS 2 0.0862 0.1316 0.2004 0.3166 0.2999 0.2075
Free Cash Flow 1 -8.189 -104.3 78.97 -350.3 -71.64 233.2
FCF margin -0.76% -9.02% 15.95% -23.92% -5.17% 16.78%
FCF Conversion (EBITDA) - - 136.39% - - 94.54%
FCF Conversion (Net income) - - 173.62% - - 381.04%
Dividend per Share 2 0.0300 - - 0.1000 0.0600 -
Announcement Date 4/27/19 4/29/20 3/30/21 3/30/22 4/25/23 4/25/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 292 380 908 509 779 761
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.437 x 3.152 x 15.69 x 2.047 x 3.778 x 3.085 x
Free Cash Flow 1 -8.19 -104 79 -350 -71.6 233
ROE (net income / shareholders' equity) 3.82% 5.34% 5.51% 6.76% 3.95% 2.92%
ROA (Net income/ Total Assets) 2.03% 1.92% -0.44% 2.67% 1.54% 2.02%
Assets 1 965 1,552 -10,394 3,211 5,740 3,036
Book Value Per Share 2 2.630 2.740 2.920 5.580 5.710 5.680
Cash Flow per Share 2 0.6400 0.5100 1.450 0.9200 0.4000 0.4800
Capex 1 74.9 48.5 24.1 111 231 137
Capex / Sales 6.92% 4.19% 4.87% 7.6% 16.67% 9.88%
Announcement Date 4/27/19 4/29/20 3/30/21 3/30/22 4/25/23 4/25/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
HANSHANG GROUP CO., LTD. Stock Hanshang Group Co., Ltd.
-26.47% 290M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600774 Stock
  4. Financials Hanshang Group Co., Ltd.